These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 25335125)

  • 1. Asenapine in the treatment of older adults with bipolar disorder.
    Sajatovic M; Dines P; Fuentes-Casiano E; Athey M; Cassidy KA; Sams J; Clegg K; Locala J; Stagno S; Tatsuoka C
    Int J Geriatr Psychiatry; 2015 Jul; 30(7):710-9. PubMed ID: 25335125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asenapine: a review of its use in the management of mania in adults with bipolar I disorder.
    Chwieduk CM; Scott LJ
    CNS Drugs; 2011 Mar; 25(3):251-67. PubMed ID: 21323396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of asenapine on depressive symptoms in patients with bipolar I disorder experiencing acute manic or mixed episodes: a post hoc analysis of two 3-week clinical trials.
    Szegedi A; Zhao J; van Willigenburg A; Nations KR; Mackle M; Panagides J
    BMC Psychiatry; 2011 Jun; 11():101. PubMed ID: 21689438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asenapine as adjunctive treatment for acute mania associated with bipolar disorder: results of a 12-week core study and 40-week extension.
    Szegedi A; Calabrese JR; Stet L; Mackle M; Zhao J; Panagides J;
    J Clin Psychopharmacol; 2012 Feb; 32(1):46-55. PubMed ID: 22198448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asenapine: Efficacy and safety of 5 and 10mg bid in a 3-week, randomized, double-blind, placebo-controlled trial in adults with a manic or mixed episode associated with bipolar I disorder.
    Landbloom RL; Mackle M; Wu X; Kelly L; Snow-Adami L; McIntyre RS; Mathews M; Hundt C
    J Affect Disord; 2016 Jan; 190():103-110. PubMed ID: 26496015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term Safety of Asenapine in Pediatric Patients Diagnosed With Bipolar I Disorder: A 50-Week Open-Label, Flexible-Dose Trial.
    Findling RL; Landbloom RL; Mackle M; Wu X; Snow-Adami L; Chang K; Durgam S
    Paediatr Drugs; 2016 Oct; 18(5):367-78. PubMed ID: 27461426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The geriatric mania asenapine study (GeMS).
    Barak Y; Finkelstein I; Pridan S
    Arch Gerontol Geriatr; 2016; 64():111-4. PubMed ID: 26952385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 3-week, randomized, placebo-controlled trial of asenapine in the treatment of acute mania in bipolar mania and mixed states.
    McIntyre RS; Cohen M; Zhao J; Alphs L; Macek TA; Panagides J
    Bipolar Disord; 2009 Nov; 11(7):673-86. PubMed ID: 19839993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asenapine versus olanzapine in acute mania: a double-blind extension study.
    McIntyre RS; Cohen M; Zhao J; Alphs L; Macek TA; Panagides J
    Bipolar Disord; 2009 Dec; 11(8):815-26. PubMed ID: 19832806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and Tolerability of Asenapine Compared with Olanzapine in Borderline Personality Disorder: An Open-Label Randomized Controlled Trial.
    Bozzatello P; Rocca P; Uscinska M; Bellino S
    CNS Drugs; 2017 Sep; 31(9):809-819. PubMed ID: 28741044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerability of asenapine for acute mania in bipolar I disorder: meta-analyses of randomized-controlled trials.
    Vita A; De Peri L; Siracusano A; Sacchetti E;
    Int Clin Psychopharmacol; 2013 Sep; 28(5):219-27. PubMed ID: 23719049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and Safety of Asenapine Versus Olanzapine in Combination With Divalproex for Acute Mania: A Randomized Controlled Trial.
    Mahajan V; Arora M; Tandon VR; Gillani Z; Praharaj SK
    J Clin Psychopharmacol; 2019; 39(4):305-311. PubMed ID: 31205195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early improvement as a predictor of acute treatment outcome in manic or mixed episodes in bipolar-1 disorder: a pooled, post hoc analysis from the asenapine development program.
    Szegedi A; Zhao J; McIntyre RS
    J Affect Disord; 2013 Sep; 150(3):745-52. PubMed ID: 23473546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asenapine in clinical practice: preliminary results from a naturalistic observational study.
    Gramaglia C; Rizza MC; Gattoni E; Gambaro E; Di Marco S; Coppola I; Rossi A; Jona A; Imperatori F; Prosperini P; Chieppa N; Binda V; Farruggio S; Grossini E; Zeppegno P
    Riv Psichiatr; 2014; 49(6):241-6. PubMed ID: 25668625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of asenapine in the treatment of bipolar I disorder patients with mixed episodes.
    Sawyer L; Azorin JM; Chang S; Rinciog C; Guiraud-Diawara A; Marre C; Hansen K
    J Med Econ; 2014 Jul; 17(7):508-19. PubMed ID: 24720805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asenapine in the treatment of acute mania in bipolar I disorder: a randomized, double-blind, placebo-controlled trial.
    McIntyre RS; Cohen M; Zhao J; Alphs L; Macek TA; Panagides J
    J Affect Disord; 2010 Apr; 122(1-2):27-38. PubMed ID: 20096936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asenapine for long-term treatment of bipolar disorder: a double-blind 40-week extension study.
    McIntyre RS; Cohen M; Zhao J; Alphs L; Macek TA; Panagides J
    J Affect Disord; 2010 Nov; 126(3):358-65. PubMed ID: 20537396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risperidone in the treatment of mixed state bipolar patients: results from a 24-week, multicenter, open-label study in Korea.
    Woo YS; Bahk WM; Jon DI; Chung SK; Lee SY; Ahn YM; Pae CU; Cho HS; Kim JG; Hwang TY; Lee HS; Min KJ; Lee KU; Yoon BH
    Psychiatry Clin Neurosci; 2010 Feb; 64(1):28-37. PubMed ID: 19895394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multisite, open-label, prospective trial of lamotrigine for geriatric bipolar depression: a preliminary report.
    Sajatovic M; Gildengers A; Al Jurdi RK; Gyulai L; Cassidy KA; Greenberg RL; Bruce ML; Mulsant BH; Ten Have T; Young RC
    Bipolar Disord; 2011 May; 13(3):294-302. PubMed ID: 21676132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjunctive long-acting risperidone in patients with bipolar disorder who relapse frequently and have active mood symptoms.
    Macfadden W; Adler CM; Turkoz I; Haskins JT; Turner N; Alphs L
    BMC Psychiatry; 2011 Oct; 11():171. PubMed ID: 22034906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.